Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial

被引:0
|
作者
Vaz, Maria Angeles
Girones, Regina
Del Barco, Sonia
Sanchez, Juan Manuel Sepulveda
Alonso, Miriam
Pineda, Estela
Balana, Carmen
Martinez-Garcia, Maria
机构
[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[2] Hosp Univ & Politecn La Fe, Med Oncol Serv, Valencia, Spain
[3] Inst Catal Oncol Girona, Med Oncol Serv, Girona, Spain
[4] Hosp Univ 12 Octubre, Med Oncol Serv, Madrid, Spain
[5] Hosp Virgen Rocio, Med Oncol Serv, Seville, Spain
[6] Hosp Clin Barcelona, Med Oncol Serv, Barcelona, Spain
[7] Inst Catal Oncol, Med Oncol Serv, Badalona, Spain
[8] Hosp Mar, Med Oncol Serv, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2060
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
    Frank Saran
    Liam Welsh
    Allan James
    Catherine McBain
    Rao Gattamaneni
    Sarah Jefferies
    Fiona Harris
    Karine Pemberton
    Jennifer Schaible
    Shaun Bender
    Agnieszka Cseh
    Michael Brada
    Journal of Neuro-Oncology, 2021, 155 : 307 - 317
  • [22] A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
    Ma, Daniel J.
    Galanis, Evanthia
    Anderson, S. Keith
    Schiff, David
    Kaufmann, Timothy J.
    Peller, Patrick J.
    Giannini, Caterina
    Brown, Paul D.
    Uhm, Joon H.
    McGraw, Steven
    Jaeckle, Kurt A.
    Flynn, Patrick J.
    Ligon, Keith L.
    Buckner, Jan C.
    Sarkaria, Jann N.
    NEURO-ONCOLOGY, 2015, 17 (09) : 1261 - 1269
  • [23] Phase IB trial of pegylated arginine deiminase (ADI-PEG 20) plus radiotherapy and temozolomide in patients with newly diagnosed glioblastoma
    Bomalaski, John S.
    Chen, Ko-Ting
    Chuang, Ming-Jung
    Liau, Chi-Ting
    Peng, Meng-Ting
    Chen, Pin-Yuan
    Lee, Cheng-Chi
    Johnston, Amanda
    Liu, Hui-Fen
    Huang, Ya-Lun S.
    Kuo, Chih-Ling
    Shiu, Chiung-Fang
    Hsu, Peng-Wei
    Chuan, Chi-Cheng
    Lai, Dar-Ming
    Wei, Kuo-Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] SAFETY AND EFFICACY OF TEMOZOLOMIDE TREATMENT WITH NEWLY DIAGNOSED GLIOBLASTOMA IN JAPAN: A MULTICENTER PHASE II CLINICAL STUDY
    Sugiyama, Kazuhiko
    Nishikawa, Ryo
    Takeshima, Hideo
    Nakamura, Hideo
    Aoki, Tomokazu
    Takahashi, Jun
    Takahash, Hideaki
    Saito, Akihiko
    Sawamura, Yutaka
    Kurisu, Kaoru
    Matsutani, Masao
    NEURO-ONCOLOGY, 2009, 11 (06) : 948 - 948
  • [25] SAFETY ANALYSIS OF RANDOMIZED BELGIAN PHASE II TRIAL OF EXTENDED USE OF ADJUVANT TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS
    Renard, L.
    Clement, P. M.
    Hammouch, F.
    Boterberg, T.
    Verschaeve, V.
    Whenham, N.
    Mitine, C.
    Devriendt, D.
    Baurain, J.
    NEURO-ONCOLOGY, 2010, 12 : 46 - 47
  • [26] Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma.
    Molaie, Donna
    Lai, Albert
    Ellingson, Benjamin M.
    Thien Nguyen
    Bahng, Hye Hyun
    Filka, Emese
    Green, Stacey
    Pope, Whitney B.
    Leng, Mei
    Yong, William H.
    Green, Richard M.
    Polikoff, Jonathan
    Spier, Liz
    Iwamoto, Fabio Massaiti
    Lassman, Andrew B.
    Cloughesy, Timothy Francis
    Nghiemphu, Phioanh Leia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Marc
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Piantadosi, Steven
    Fisher, Joy
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
  • [28] Safety and efficacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma - the PriCoTTF phase I/II trial
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Feldheim, Jonas
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca Ligia
    Krex, Dietmar
    Pierscianek, Daniela
    Sure, Ulrich
    Scheffler, Bjoern
    Kleinschnitz, Christoph
    Stuschke, Martin
    Glas, Martin
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S32 - S32
  • [29] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Thomas, Alissa A.
    Beal, Kathryn
    McNeill, Katharine Anne
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Perez, Julio Arevalo
    Yamada, Yoshiya
    Anderson, Barry Douglas
    Lamson, Michael
    Burch, Brandon
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    NEURO-ONCOLOGY, 2011, 13 : 128 - 128